|
|
||||||||
The Annals of Thoracic Surgery, Vol 56, 1117-1122, Copyright © 1993 by The Society of Thoracic Surgeons
HP Zweep, S Satoh, B van der Lei, WL Hinrichs, J Feijen and CR Wildevuur
In a previous study, we implanted autologous vein grafts in the carotid
artery of rabbits supported by a compliant, biodegradable prosthesis to
prevent vein wall damage due to the higher arterial pressure. We showed
that such a supporting prosthesis indeed reduces damage to these vein
grafts and allows for more regular and gradual arterialization than that
afforded by unsupported vein grafts. To evaluate the influence of the rate
of biodegradation of such a supporting prosthesis on the process of
arterialization of autologous vein grafts, we implanted vein grafts
supported with prostheses, which degrade within 3 weeks (group I), 6 weeks
(group II), or 3 months (group III), into the carotid artery of rabbits,
and then evaluated them up to 6 weeks after implantation. At 6 weeks, the
group I vein grafts showed a thinner vein wall than did the adjacent artery
during dilatation. In group II, the vein wall thickness and luminal
diameter had completely adjusted to that of the adjacent carotid artery.
The group III vein grafts showed a significantly thinner vein wall in the
absence of dilatation. All supported vein grafts showed regular
longitudinally oriented and, in some areas, circularly oriented cell
layers, together with thin elastic laminae, which were most pronounced in
group II. We conclude that a supporting, compliant prosthesis can
stimulate, regulate, and optimize the arterialization of autologous vein
grafts in rabbits. If the rate of degradation is carefully chosen, the
radius and wall thickness of the vein graft can completely adjust to that
of the adjacent artery.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Degradation of a supporting prosthesis can optimize arterialization of autologous veins
Cardiopulmonary Surgery Research Division, University Hospital Groningen, The Netherlands.
This article has been cited by other articles:
![]() |
P. Zilla, P. Human, M. Wolf, W. Lichtenberg, N. Rafiee, D. Bezuidenhout, N. Samodien, C. Schmidt, and T. Franz Constrictive external nitinol meshes inhibit vein graft intimal hyperplasia in nonhuman primates J. Thorac. Cardiovasc. Surg., September 1, 2008; 136(3): 717 - 725. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Jeremy, R. Bulbulia, J. L. Johnson, P. Gadsdon, V. Vijayan, N. Shukla, F. C. T. Smith, and G. D. Angelini A bioabsorbable (polyglactin), nonrestrictive, external sheath inhibits porcine saphenous vein graft thickening J. Thorac. Cardiovasc. Surg., June 1, 2004; 127(6): 1766 - 1772. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Q. Liu Focal Expression of Angiotensin II Type 1 Receptor and Smooth Muscle Cell Proliferation in the Neointima of Experimental Vein Grafts : Relation to Eddy Blood Flow Arterioscler Thromb Vasc Biol, November 1, 1999; 19(11): 2630 - 2639. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Brauner, H. Laks, D. C. Drinkwater Jr., G. Chaudhuri, O. Shvarts, T. Drake, S. Bhuta, D. Mishaly, I. Fishbein, and G. Golomb CONTROLLED PERIADVENTITIAL ADMINISTRATION OF VERAPAMIL INHIBITS NEOINTIMAL SMOOTH MUSCLE CELL PROLIFERATION AND AMELIORATES VASOMOTOR ABNORMALITIES IN EXPERIMENTAL VEIN BYPASS GRAFTS J. Thorac. Cardiovasc. Surg., July 1, 1997; 114(1): 53 - 63. [Abstract] [Full Text] |
||||
![]() |
A. Chaux, X. M. Ruan, M. C. Fishbein, M. Sandhu, and J. M. Matloff INFLUENCE OF VEIN VALVES IN THE DEVELOPMENT OF ARTERIOSCLEROSIS IN VENOARTERIAL GRAFTS IN THE RABBIT J. Thorac. Cardiovasc. Surg., November 1, 1995; 110(5): 1381 - 1390. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |